Literature DB >> 24982520

Botulinum toxin A as a treatment for delayed gastric emptying in a dog.

Max L Rinaldi1, Boel A Fransson1, Sabrina L Barry1.   

Abstract

A toy Australian shepherd dog was referred for bile peritonitis following excision of a biliary mucocele. Subsequent delayed gastric emptying was refractory to prokinetic therapy but responded to injection of botulinum toxin A into the muscularis layer of the pylorus; a novel therapy for delayed gastric emptying in dogs.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24982520      PMCID： PMC4060911     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  24 in total

Review 1.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

2.  Gastroparesis: current concepts and management.

Authors:  Tatsuhiro Masaoka; Jan Tack
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

Review 3.  A systematic review on intrapyloric botulinum toxin injection for gastroparesis.

Authors:  Yu Bai; Mao-Jin Xu; Xia Yang; Can Xu; Jun Gao; Duo-Wu Zou; Zhao-Shen Li
Journal:  Digestion       Date:  2009-12-22       Impact factor: 3.216

4.  A comparison of common bile duct pressures after botulinum toxin injection into the sphincter of Oddi versus biliary stenting in a canine model.

Authors:  J M Marks; A L Bower; M Goormastic; J L Malycky; J L Ponsky
Journal:  Am J Surg       Date:  2001-01       Impact factor: 2.565

Review 5.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.

Authors:  T Wehrmann; T H Schmitt; A Arndt; B Lembcke; W F Caspary; H Seifert
Journal:  Aliment Pharmacol Ther       Date:  2000-11       Impact factor: 8.171

Review 7.  Treatment of refractory gastroparesis: gastric and jejunal tubes, botox, gastric electrical stimulation, and surgery.

Authors:  Reza A Hejazi; Richard W McCallum
Journal:  Gastrointest Endosc Clin N Am       Date:  2009-01

Review 8.  Botulinum toxin type A for treatment of refractory gastroparesis.

Authors:  Evelyn R Hermes DeSantis; Sheilyn Huang
Journal:  Am J Health Syst Pharm       Date:  2007-11-01       Impact factor: 2.637

9.  Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.

Authors:  J Arts; L Holvoet; P Caenepeel; R Bisschops; D Sifrim; K Verbeke; J Janssens; J Tack
Journal:  Aliment Pharmacol Ther       Date:  2007-11-01       Impact factor: 8.171

10.  Intestinal control of human postprandial gastric function: the role of components of jejunoileal chyme in regulating gastric secretion and gastric emptying.

Authors:  L J Miller; J R Malagelada; W F Taylor; V L Go
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682
View more
  1 in total

1.  Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat.

Authors:  Robert I McGeachan; Tobias Schwarz; Danièlle A Gunn-Moore; Katia Marioni-Henry
Journal:  JFMS Open Rep       Date:  2020-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.